Skip to main content
Top
Published in: Digestive Diseases and Sciences 4/2012

01-04-2012 | Original Article

Impact of Helicobacter pylori Infection and Microscopic Duodenal Histopathological Changes on Clinical Symptoms of Patients with Functional Dyspepsia

Authors: Seyed Amir Mirbagheri, Nasim Khajavirad, Nasser Rakhshani, Mohammad Reza Ostovaneh, Seyed Mahmood Eshagh Hoseini, Vahid Hoseini

Published in: Digestive Diseases and Sciences | Issue 4/2012

Login to get access

Abstract

Aim

To evaluate the microscopic histopathological changes in duodenal tissue and its relationship to the severity of symptoms in patients with functional dyspepsia while taking the effect of Helicobacter pylori (H. pylori) infection into account.

Methods

Several gastric and duodenal biopsy specimens were obtained in 217 patients with functional dyspepsia and were evaluated for H. pylori infection and histopathological changes. Severity of symptoms was assessed by Leeds Dyspepsia Questionnaire (LDQ) and its relationship to histopathological changes and H. pylori infection status was assessed.

Results

Helicobacter pylori infection was associated with presence and severity of microscopic duodenitis (p < 0.001). In H. pylori-infected patients, the presence of microscopic duodenitis was independent of microscopic gastritis (p = 0.74). Severity of dyspepsia symptoms was not higher in H. pylori-infected patients than non-infected patients (p = 0.15), but in the presence of H. pylori infection and microscopic gastritis, microscopic duodenitis significantly worsened the LDQ symptom severity score (p < 0.001). In multivariate analysis, the odds of experiencing severe symptoms in patients with severe microscopic duodenitis was 2.22 times greater than in individuals with very mild, mild, or moderate duodenitis.

Conclusions

Microscopic duodenitis in H. pylori-infected patients may play a major role in producing and aggravating symptoms in FD patients and may be a determinant factor to consider in whether to treat H. pylori infection in functional dyspepsia.
Literature
1.
go back to reference Leidy NK, Farup C, Rentz AM, Ganoczy D, Koch KL. Patient-based assessment in dyspepsia: development and validation of Dyspepsia Symptom Severity Index (DSSI). Dig Dis Sci. 2000;45:1172–1179.PubMedCrossRef Leidy NK, Farup C, Rentz AM, Ganoczy D, Koch KL. Patient-based assessment in dyspepsia: development and validation of Dyspepsia Symptom Severity Index (DSSI). Dig Dis Sci. 2000;45:1172–1179.PubMedCrossRef
2.
go back to reference El-Serag HB, Talley NJ. Systemic review: the prevalence and clinical course of functional dyspepsia. Aliment Pharmacol Ther. 2004;19:643–654.PubMedCrossRef El-Serag HB, Talley NJ. Systemic review: the prevalence and clinical course of functional dyspepsia. Aliment Pharmacol Ther. 2004;19:643–654.PubMedCrossRef
3.
go back to reference Mc Namara DA, Buckley M, O’Morain CA. Nonulcer dyspepsia. Current concepts and management. Gastroenterol Clin North Am. 2000;29:807–818.PubMedCrossRef Mc Namara DA, Buckley M, O’Morain CA. Nonulcer dyspepsia. Current concepts and management. Gastroenterol Clin North Am. 2000;29:807–818.PubMedCrossRef
4.
go back to reference Talley NJ, Stanghellini V, Heading RC, Koch KL, Malagelada JR, Tytgat GN. Functional gastroduodenal disorders. Gut. 1999;45:II37–II42.PubMedCrossRef Talley NJ, Stanghellini V, Heading RC, Koch KL, Malagelada JR, Tytgat GN. Functional gastroduodenal disorders. Gut. 1999;45:II37–II42.PubMedCrossRef
5.
go back to reference Tack J, Talley NJ, Camilleri M, et al. Functional gastroduodenal disorders. Gastroenterology. 2006;130:1466–1479.PubMedCrossRef Tack J, Talley NJ, Camilleri M, et al. Functional gastroduodenal disorders. Gastroenterology. 2006;130:1466–1479.PubMedCrossRef
6.
go back to reference Drossman DA, Corazziari E, Delvaux M, Spiller R, Talley NJ, Thompson WG. Appendix B: Rome III diagnostic criteria for functional gastrointestinal disorders. Rev Gastroenterol Mex. 2010;75:511–516.PubMed Drossman DA, Corazziari E, Delvaux M, Spiller R, Talley NJ, Thompson WG. Appendix B: Rome III diagnostic criteria for functional gastrointestinal disorders. Rev Gastroenterol Mex. 2010;75:511–516.PubMed
7.
go back to reference Loyd RA, McClellan DA. Update on the evaluation and management of functional dyspepsia. Am Fam Phys. 2011;83:547–552. Loyd RA, McClellan DA. Update on the evaluation and management of functional dyspepsia. Am Fam Phys. 2011;83:547–552.
8.
go back to reference Go MF. Review article: natural history and epidemiology of Helicobacter pylori infection. Aliment Pharmacol Ther. 2002;16:3–15.PubMedCrossRef Go MF. Review article: natural history and epidemiology of Helicobacter pylori infection. Aliment Pharmacol Ther. 2002;16:3–15.PubMedCrossRef
9.
go back to reference Graham DY, Adam E, Reddy GT, et al. Seroepidemiology of Helicobacter pylori infection in India. Comparison of developing and developed countries. Dig Dis Sci. 1991;36:1084–1088.PubMedCrossRef Graham DY, Adam E, Reddy GT, et al. Seroepidemiology of Helicobacter pylori infection in India. Comparison of developing and developed countries. Dig Dis Sci. 1991;36:1084–1088.PubMedCrossRef
10.
go back to reference Malfertheiner P, Megraud F, O’Morain C, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III consensus report. Gut. 2007;56:772–781.PubMedCrossRef Malfertheiner P, Megraud F, O’Morain C, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III consensus report. Gut. 2007;56:772–781.PubMedCrossRef
11.
go back to reference Nakajima S, Nishiyama Y, Yamaoka M, Yasuoka T, Cho E. Changes in the prevalence of Helicobacter pylori infection and gastrointestinal diseases in the past 17 years. J Gastroenterol Hepatol. 2010;25:S99–S110.PubMedCrossRef Nakajima S, Nishiyama Y, Yamaoka M, Yasuoka T, Cho E. Changes in the prevalence of Helicobacter pylori infection and gastrointestinal diseases in the past 17 years. J Gastroenterol Hepatol. 2010;25:S99–S110.PubMedCrossRef
12.
go back to reference Alazmi WM, Siddique I, Alateeqi N, Al-Nakib B. Prevalence of Helicobacter pylori infection among new outpatients with dyspepsia in Kuwait. BMC Gastroenterol. 2010;10:14.PubMedCrossRef Alazmi WM, Siddique I, Alateeqi N, Al-Nakib B. Prevalence of Helicobacter pylori infection among new outpatients with dyspepsia in Kuwait. BMC Gastroenterol. 2010;10:14.PubMedCrossRef
13.
go back to reference Delaney B, Ford AC, Forman D, Moayyedi P, Qume M. Initial management strategies for dyspepsia. Cochrane Database Syst Rev. 2005;CD001961. Delaney B, Ford AC, Forman D, Moayyedi P, Qume M. Initial management strategies for dyspepsia. Cochrane Database Syst Rev. 2005;CD001961.
14.
go back to reference Moayyedi P, Soo S, Deeks J, Delaney B, Harris A, Innes M, et al. Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev. 2000;CD002096. Moayyedi P, Soo S, Deeks J, Delaney B, Harris A, Innes M, et al. Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev. 2000;CD002096.
15.
go back to reference Joshi A, Ahuja V, Duttagupta S, Sharma M. Correlation of presence of H. pylori with histological and symptomatic score in patients with non ulcer dyspepsia (NUD). J Gastroenterol Hepatol. 2000;15:H8.CrossRef Joshi A, Ahuja V, Duttagupta S, Sharma M. Correlation of presence of H. pylori with histological and symptomatic score in patients with non ulcer dyspepsia (NUD). J Gastroenterol Hepatol. 2000;15:H8.CrossRef
16.
go back to reference Fock KM. Functional dyspepsia, H. pylori and post infectious FD. J Gastroenterol Hepatol. 2011;26:39–41.PubMedCrossRef Fock KM. Functional dyspepsia, H. pylori and post infectious FD. J Gastroenterol Hepatol. 2011;26:39–41.PubMedCrossRef
17.
go back to reference Suzuki H, Nishizawa T, Hibi T. Can Helicobacter pylori-associated dyspepsia be categorized as functional dyspepsia? J Gastroenterol Hepatol. 2011;26:42–45.PubMedCrossRef Suzuki H, Nishizawa T, Hibi T. Can Helicobacter pylori-associated dyspepsia be categorized as functional dyspepsia? J Gastroenterol Hepatol. 2011;26:42–45.PubMedCrossRef
18.
go back to reference Urakami Y, Sano T. Endoscopic duodenitis, gastric metaplasia and Helicobacter pylori. J Gastroenterol Hepatol. 2001;16:513–518.PubMedCrossRef Urakami Y, Sano T. Endoscopic duodenitis, gastric metaplasia and Helicobacter pylori. J Gastroenterol Hepatol. 2001;16:513–518.PubMedCrossRef
19.
go back to reference Sari YS, Sander E, Erkan E, Tunali V. Endoscopic diagnoses and CLO test results in 9239 cases, prevalence of Helicobacter pylori in Istanbul, Turkey. J Gastroenterol Hepatol. 2007;22:1706–1711.PubMedCrossRef Sari YS, Sander E, Erkan E, Tunali V. Endoscopic diagnoses and CLO test results in 9239 cases, prevalence of Helicobacter pylori in Istanbul, Turkey. J Gastroenterol Hepatol. 2007;22:1706–1711.PubMedCrossRef
20.
go back to reference Graham DY. Campylobacter pylori and peptic ulcer disease. Gastroenterology. 1989;96:615–625.PubMed Graham DY. Campylobacter pylori and peptic ulcer disease. Gastroenterology. 1989;96:615–625.PubMed
21.
go back to reference Genta RM, Kinsey RS, Singhal A, Suterwala S. Gastric foveolar metaplasia and gastric heterotopia in the duodenum: no evidence of an etiologic role for Helicobacter pylori. Hum Pathol. 2010;41:1593–1600.PubMedCrossRef Genta RM, Kinsey RS, Singhal A, Suterwala S. Gastric foveolar metaplasia and gastric heterotopia in the duodenum: no evidence of an etiologic role for Helicobacter pylori. Hum Pathol. 2010;41:1593–1600.PubMedCrossRef
22.
go back to reference D’costa FG, Dutta S, Patil YV. Histopathology of gastro-duodenal biopsies and Helicobacter pylori Infection. BHJ. 2007;4902:292–300. D’costa FG, Dutta S, Patil YV. Histopathology of gastro-duodenal biopsies and Helicobacter pylori Infection. BHJ. 2007;4902:292–300.
23.
go back to reference Wyatt JI, Rathbone BJ, Heatley RV. Local immune response to gastric Campylobacter in non-ulcer dyspepsia. J Clin Pathol. 1986;39:863–870.PubMedCrossRef Wyatt JI, Rathbone BJ, Heatley RV. Local immune response to gastric Campylobacter in non-ulcer dyspepsia. J Clin Pathol. 1986;39:863–870.PubMedCrossRef
24.
go back to reference Drossman DA, Dumitrascu DL. Rome III: new standard for functional gastrointestinal disorders. J Gastrointest Liver Dis. 2006;15:237. Drossman DA, Dumitrascu DL. Rome III: new standard for functional gastrointestinal disorders. J Gastrointest Liver Dis. 2006;15:237.
25.
go back to reference Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International workshop on the histopathology of gastritis, Houston 1994. Am J Surg Pathol. 1996;20:1161–1181.PubMedCrossRef Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International workshop on the histopathology of gastritis, Houston 1994. Am J Surg Pathol. 1996;20:1161–1181.PubMedCrossRef
26.
go back to reference Genta RM, Gürer IE, Graham DY. Geographical pathology of Helicobacter pylori infection: is there more than one gastritis? Ann Med. 1995;27:595–599.PubMedCrossRef Genta RM, Gürer IE, Graham DY. Geographical pathology of Helicobacter pylori infection: is there more than one gastritis? Ann Med. 1995;27:595–599.PubMedCrossRef
27.
go back to reference Moayyedi P, Duffett S, Braunholtz D, et al. The Leeds Dyspepsia Questionnaire: a valid tool for measuring the presence and severity of dyspepsia. Aliment Pharmacol Ther. 1998;12:1257–1262.PubMedCrossRef Moayyedi P, Duffett S, Braunholtz D, et al. The Leeds Dyspepsia Questionnaire: a valid tool for measuring the presence and severity of dyspepsia. Aliment Pharmacol Ther. 1998;12:1257–1262.PubMedCrossRef
28.
go back to reference Dickerson LM, King DE. Evaluation and management of nonulcer dyspepsia. Am Fam Phys. 2004;70:107–114. Dickerson LM, King DE. Evaluation and management of nonulcer dyspepsia. Am Fam Phys. 2004;70:107–114.
29.
go back to reference Moayyedi P, Soo S, Deeks J, Delaney B, Harris A, Innes M, et al. Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev. 2006;CD002096. Moayyedi P, Soo S, Deeks J, Delaney B, Harris A, Innes M, et al. Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev. 2006;CD002096.
30.
go back to reference Leoci C, Ierardi E, Chiloiro M, et al. Incidence and risk factors of duodenal ulcer: a retrospective cohort study. J Clin Gastroenterol. 1995;20:104.PubMedCrossRef Leoci C, Ierardi E, Chiloiro M, et al. Incidence and risk factors of duodenal ulcer: a retrospective cohort study. J Clin Gastroenterol. 1995;20:104.PubMedCrossRef
31.
go back to reference Asfeldt AM, Steigen SE, Lochen ML, et al. The natural course of Helicobacter pylori infection on endoscopic findings in a population during 17 years of follow-up: the Sorreisa Gastrointestinal Disorder Study. Eur J Epidemiol. 2009;24:649–658.PubMedCrossRef Asfeldt AM, Steigen SE, Lochen ML, et al. The natural course of Helicobacter pylori infection on endoscopic findings in a population during 17 years of follow-up: the Sorreisa Gastrointestinal Disorder Study. Eur J Epidemiol. 2009;24:649–658.PubMedCrossRef
32.
go back to reference Okumura T, Tanno S, Ohhira M. Prevalence of functional dyspepsia in an outpatient clinic with primary care physicians in Japan. J Gastroenterol. 2010;45:187–194.PubMedCrossRef Okumura T, Tanno S, Ohhira M. Prevalence of functional dyspepsia in an outpatient clinic with primary care physicians in Japan. J Gastroenterol. 2010;45:187–194.PubMedCrossRef
Metadata
Title
Impact of Helicobacter pylori Infection and Microscopic Duodenal Histopathological Changes on Clinical Symptoms of Patients with Functional Dyspepsia
Authors
Seyed Amir Mirbagheri
Nasim Khajavirad
Nasser Rakhshani
Mohammad Reza Ostovaneh
Seyed Mahmood Eshagh Hoseini
Vahid Hoseini
Publication date
01-04-2012
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 4/2012
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-011-1960-z

Other articles of this Issue 4/2012

Digestive Diseases and Sciences 4/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.